Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-11-10 10:27 am Sale | 13G | AKCEA THERAPEUTICS INC. AKCA | FMR LLC | 0 0.000% | -5,716,836 (Position Closed) | View |
| 2020-10-13 10:35 am Sale | 13G | AKCEA THERAPEUTICS INC. AKCA | FMR LLC | 5,716,836 5.625% | -5,079,303 (-47.05%) | View |
| 2020-10-13 08:47 am Sale | 13D | AKCEA THERAPEUTICS INC. AKCA | IONIS PHARMACEUTICALS INC IONS | 1,000 100.000% | -77,093,682 (-100.00%) | View |
| 2020-08-31 07:12 am Unchanged | 13D | AKCEA THERAPEUTICS INC. AKCA | IONIS PHARMACEUTICALS INC IONS | 77,094,682 75.900% | 0 (Unchanged) | View |
| 2020-02-07 11:12 am Sale | 13G | AKCEA THERAPEUTICS INC. AKCA | FMR LLC | 10,796,139 11.497% | -2,585,367 (-19.32%) | View |
| 2019-12-19 5:55 pm Purchase | 13D | AKCEA THERAPEUTICS INC. AKCA | IONIS PHARMACEUTICALS INC IONS | 77,094,682 76.500% | 6,873,344 (+9.79%) | View |